NCT04420793

Brief Summary

Depressed patients talk differently when they are depressed compared to when they are well. But it is hard to actually measure what the differences are. The study team will record voice samples from patients with mood disturbances, like depression, over the course of their receiving an electroconvulsive therapy (ECT) series. The study team will try and measure or quantify exactly what has changed in their speech and voice. The study team will choose ECT as it is one of the most effective and rapid treatment for depression. The study team will use a service provided by a company, NeuroLex, who has complex computer programs (artificial intelligence, AI) to analyze the voice samples.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2021

Completed
Last Updated

October 24, 2024

Status Verified

October 1, 2024

Enrollment Period

1.3 years

First QC Date

March 10, 2020

Last Update Submit

October 22, 2024

Conditions

Keywords

VAPRE

Outcome Measures

Primary Outcomes (22)

  • Acoustic feature: zero crossing rate

    crossings per second

    Throughout a course of electroconvulsive therapy (ECT) which may last between 2 and 7 weeks.

  • Acoustic feature: energy and entropy

    decibels

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Acoustic feature: spectral centroid, spectral spread, spectral entropy, spectral flux, spectral rolloff

    hertz

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Acoustic feature: Mel-Frequency Cepstral Coefficients, Chroma Vectors, and Chroma Deviation

    unitless

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic features: question ratio, filler ratio, number ratio, type token ratio

    unitless ratio

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic features: verb frequency, noun frequency, pronoun frequency, adverb frequency, adjective frequency, particle frequency, conjunction frequency, pronoun frequency

    percentage

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic features: standardized word entropy

    decibels/log(total word count)

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic features: Brunets index

    W (lexical richness)

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic features: Honores statistic

    R (lexical richness)

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic features: rate of speech

    words per minute

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: fatigue

    Machine learning approach to evaluate binary outcome: fatigued or awake

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: audio quality

    Machine learning approach to evaluate binary outcome: bad or good

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: sentiment

    Machine learning approach to evaluate binary outcome: sad or happy

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: stress

    Machine learning approach to evaluate binary outcome: stressed or not stressed

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: gender

    Machine learning approach to evaluate binary outcome: male or female

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: accent

    Machine learning approach to evaluate a categorical outcome of accent region: england, indian, australian, etc.

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: length

    seconds

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-features: age

    Machine learning approach to evaluate estimated decade-age: 10s, 20s, 30s, 40s, 50s, 60s, 70s, 80s, 90s, etc.

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Comparing the voice feature(s) with greatest statistically significant change to Patient Health Questionnaire (PHQ)-9 scores

    The voice feature(s) found to have changed most significantly will be compared to Patient Health Questionnaire-9 scores which approach a total score that is less than 8, indicative of reduced depressive symptoms throughout Electroconvulsive Therapy

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Acoustic Feature Specific Changes within and across sessions

    Generalized mixed linear model will be used to evaluate which acoustic features change with P value threshold of \<0.05

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic Feature Specific Changes within and across sessions

    Generalized mixed linear model will be used to evaluate which linguistic features change with P value threshold of \<0.05

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-Feature Specific Changes within and across sessions

    Generalized mixed linear model will be used to evaluate which meta features change with P value threshold of \<0.05

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

Secondary Outcomes (30)

  • Acoustic Feature Specific Changes between sessions

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Linguistic Feature Specific Changes between sessions

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Meta-Feature Specific Changes between sessions

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Patient Chart Review Data: Age

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • Patient Chart Review Data: inpatient/outpatient status

    Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.

  • +25 more secondary outcomes

Study Arms (1)

ECT and Voice Recorded Group

This is an add-on study of voice samples to be gathered during ECT clinical treatments. The ONLY research procedures are four tasks on an online form, one text task and three voice recording tasks. These voice recordings will take place in a private room on the 5th floor of the Institute of Psychiatry on the same day of a patient's ECT treatment. The questionnaire will take less than 10 minutes.

Other: Questionnaire

Interventions

3 voice recording tasks and 1 text entry task will be performed.

ECT and Voice Recorded Group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing electroconvulsive therapy (ECT) at the Medical University of South Carolina on an outpatient or inpatient basis.

You may qualify if:

  • Any candidate for electroconvulsive therapy who is about to initiate their ECT course at Medical University of South Carolina (MUSC) for a clinically indicated diagnosis
  • Age 18 to 90 years old
  • Able to speak and understand English
  • Able to give consent to participate in the study

You may not qualify if:

  • Any medical condition that limits the ability to speak or speak clearly, for example a history of head and/or neck cancer, spinal cord injury affecting speech, amyotrophic lateral sclerosis, or those with absence of critical anatomical structures involved in speech.
  • Patients who are receiving ECT by involuntary order, by order of their guardian, or by a court order, as evidenced by patient report or brief chart review.
  • Patients who elect to not receive their full course of ECT at MUSC.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Depressive DisorderBipolar Disorder

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Mood DisordersMental DisordersBipolar and Related Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Sean Christensen, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2020

First Posted

June 9, 2020

Study Start

November 7, 2019

Primary Completion

February 17, 2021

Study Completion

February 17, 2021

Last Updated

October 24, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations